ODI Pharma AB (publ) (NGM: ODI)
Sweden
· Delayed Price · Currency is SEK 3.560
0.00 (0.00%)
At close: Jan 28, 2025
ODI Pharma AB Revenue
ODI Pharma AB had revenue of 143.80K SEK in the quarter ending September 30, 2024, a decrease of -72.78%. This brings the company's revenue in the last twelve months to 22.06M, up 3,349.15% year-over-year. In the fiscal year ending June 30, 2024, ODI Pharma AB had annual revenue of 22.29M with 15,880.34% growth.
Revenue (ttm)
22.06M
Revenue Growth
+3,349.15%
P/S Ratio
2.35
Revenue / Employee
22.06M
Employees
1
Market Cap
51.75M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 176.78B |
| Atlas Copco AB | 176.77B |
| AB Volvo | 526.82B |
| EQT AB | 30.40B |
| ASSA ABLOY AB | 147.56B |
| Hexagon AB | 61.89B |
| Skandinaviska Enskilda Banken AB | 81.00B |
| Sandvik AB | 122.88B |